This website uses cookies to give you the best experience. By continuing to use this website you are consenting to cookies being used. You can delete and block cookies from within your browsers settings. For more information please refer to our privacy and cookie policy page.

Continue

NICE guidance on the use of Abatacept, Adalimumab, Etanercept and Tocilizumab for treating Juvenile Idiopathic Arthritis (NICE 2015)

https://www.nice.org.uk/guidance/ta373